OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3
Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 10
Open Access | Times Cited: 191
Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 10
Open Access | Times Cited: 191
Showing 1-25 of 191 citing articles:
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
Pedro Machado, Saskia Lawson‐Tovey, Anja Strangfeld, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 5, pp. 695-709
Open Access | Times Cited: 167
Pedro Machado, Saskia Lawson‐Tovey, Anja Strangfeld, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 5, pp. 695-709
Open Access | Times Cited: 167
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
Rebecca Grainger, Alfred H.J. Kim, Richard Conway, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 191-204
Open Access | Times Cited: 159
Rebecca Grainger, Alfred H.J. Kim, Richard Conway, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 191-204
Open Access | Times Cited: 159
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
Robert Landewé, Féline P B Kroon, Alessia Alunno, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1628-1639
Open Access | Times Cited: 137
Robert Landewé, Féline P B Kroon, Alessia Alunno, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1628-1639
Open Access | Times Cited: 137
Vaccines and therapeutics for immunocompromised patients with COVID-19
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 84
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 84
Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 83
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 83
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID
Kimberly N. Weaver, Xian Zhang, Xiangfeng Dai, et al.
Inflammatory Bowel Diseases (2021) Vol. 28, Iss. 10, pp. 1497-1505
Open Access | Times Cited: 83
Kimberly N. Weaver, Xian Zhang, Xiangfeng Dai, et al.
Inflammatory Bowel Diseases (2021) Vol. 28, Iss. 10, pp. 1497-1505
Open Access | Times Cited: 83
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS
Kader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 5, pp. 601-613
Open Access | Times Cited: 56
Kader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 5, pp. 601-613
Open Access | Times Cited: 56
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases
Athanasios G. Tzioufas, Athanasios‐Dimitrios Bakasis, Andreas V. Goules, et al.
Journal of Autoimmunity (2021) Vol. 125, pp. 102743-102743
Open Access | Times Cited: 55
Athanasios G. Tzioufas, Athanasios‐Dimitrios Bakasis, Andreas V. Goules, et al.
Journal of Autoimmunity (2021) Vol. 125, pp. 102743-102743
Open Access | Times Cited: 55
Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines
Yong Fan, Yan Geng, Yu Wang, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 3, pp. 443-445
Open Access | Times Cited: 55
Yong Fan, Yan Geng, Yu Wang, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 3, pp. 443-445
Open Access | Times Cited: 55
Early experience of COVID‐19 vaccine‐related adverse events among adolescents and young adults with rheumatic diseases: A single‐center study
Fatih Haşlak, Aybüke Günalp, Memnune Nur Çebi, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 3, pp. 353-363
Closed Access | Times Cited: 49
Fatih Haşlak, Aybüke Günalp, Memnune Nur Çebi, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 3, pp. 353-363
Closed Access | Times Cited: 49
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review
Po‐Chien Wu, I‐Hsin Huang, Chuang‐Wei Wang, et al.
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. 6, pp. 775-799
Open Access | Times Cited: 48
Po‐Chien Wu, I‐Hsin Huang, Chuang‐Wei Wang, et al.
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. 6, pp. 775-799
Open Access | Times Cited: 48
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik N. Albach, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 6, pp. 881-888
Open Access | Times Cited: 46
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik N. Albach, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 6, pp. 881-888
Open Access | Times Cited: 46
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
Chiara Farroni, Andrea Picchianti Diamanti, Alessandra Aiello, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Chiara Farroni, Andrea Picchianti Diamanti, Alessandra Aiello, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Immunogenicity and Safety of Standard and Third‐Dose SARS –CoV ‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 8, pp. 1321-1332
Open Access | Times Cited: 45
Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 8, pp. 1321-1332
Open Access | Times Cited: 45
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications
Merav Heshin‐Bekenstein, Amit Ziv, Nataša Toplak, et al.
Lara D. Veeken (2022) Vol. 61, Iss. 11, pp. 4263-4272
Open Access | Times Cited: 43
Merav Heshin‐Bekenstein, Amit Ziv, Nataša Toplak, et al.
Lara D. Veeken (2022) Vol. 61, Iss. 11, pp. 4263-4272
Open Access | Times Cited: 43
The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
Yan Xie, Yang Liu, Yi Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Yan Xie, Yang Liu, Yi Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases
Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Ana Cristina de Medeiros Ribeiro, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1036-1043
Open Access | Times Cited: 39
Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Ana Cristina de Medeiros Ribeiro, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1036-1043
Open Access | Times Cited: 39
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis
Jessica Widdifield, Jeffrey C. Kwong, Simon Chen, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e430-e440
Open Access | Times Cited: 38
Jessica Widdifield, Jeffrey C. Kwong, Simon Chen, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e430-e440
Open Access | Times Cited: 38
COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations
Kristine Duly, Francis A. Farraye, Shubha Bhat
American Journal of Health-System Pharmacy (2021) Vol. 79, Iss. 2, pp. 63-71
Open Access | Times Cited: 40
Kristine Duly, Francis A. Farraye, Shubha Bhat
American Journal of Health-System Pharmacy (2021) Vol. 79, Iss. 2, pp. 63-71
Open Access | Times Cited: 40
COVID‐19 vaccination in patients with rheumatic diseases: Vaccination rates, patient perspectives, and side effects
Yan Kiu Li, Michael Pak Kiu Lui, Lip Long Yam, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 33
Yan Kiu Li, Michael Pak Kiu Lui, Lip Long Yam, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 33
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS
Kate Stevens, Eleni Frangou, Jae Il Shin, et al.
Nephrology Dialysis Transplantation (2022) Vol. 37, Iss. 8, pp. 1400-1410
Open Access | Times Cited: 28
Kate Stevens, Eleni Frangou, Jae Il Shin, et al.
Nephrology Dialysis Transplantation (2022) Vol. 37, Iss. 8, pp. 1400-1410
Open Access | Times Cited: 28
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE /PRAAS , SAVI , and AGS
Kader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 5, pp. 735-751
Closed Access | Times Cited: 28
Kader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 5, pp. 735-751
Closed Access | Times Cited: 28
Effect of Systemic Lupus Erythematosus and Immunosuppressive Agents on COVID ‐19 Vaccination Antibody Response
Michelle Petri, Daniel Joyce, Kristin Haag, et al.
Arthritis Care & Research (2023) Vol. 75, Iss. 9, pp. 1878-1885
Open Access | Times Cited: 19
Michelle Petri, Daniel Joyce, Kristin Haag, et al.
Arthritis Care & Research (2023) Vol. 75, Iss. 9, pp. 1878-1885
Open Access | Times Cited: 19
Self‐Reported Delayed Adverse Events and Flare Following COVID ‐19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD ) in Malaysia: Results From the COVAD ‐2 Study
Syahrul Sazliyana Shaharir, Azmawati Mohammed Nawi, Theepa Nesam Mariamutu, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access
Syahrul Sazliyana Shaharir, Azmawati Mohammed Nawi, Theepa Nesam Mariamutu, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access
